Stay updated on GARNET: Anti-PD-1 Antibody Clinical Trial
Sign up to get notified when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.

Latest updates to the GARNET: Anti-PD-1 Antibody Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page. No study data or user-facing functionality appears to be changed.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 removed; this is a minor site-version update that does not affect the study details or navigation.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedAdded glossary toggle, new metadata entries (Last Update Submitted that Met QC Criteria, Last Update Posted), No FEAR Act Data, and a revision badge (Revision: v3.4.0). Removed older entries (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4).SummaryDifference0.1%

- Check50 days agoChange DetectedEnrollment updated to 730 and the study location count updated to 105. Multiple sites across Spain, South Korea, Mexico, Brazil, Argentina, and Poland were removed and location-related notes were revised.SummaryDifference4%

- Check79 days agoChange DetectedAdded a new Locations section listing trial sites across US states (e.g., Alabama, Arizona, California, District of Columbia, Florida, etc.) and Canadian provinces (Alberta, British Columbia, Ontario, Quebec) under revision v3.3.3; the previous revision’s location sections (v3.3.2) were removed.SummaryDifference1%

Stay in the know with updates to GARNET: Anti-PD-1 Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.